APOE and Cognitive impairment: Since one year increase in age has a 6% increased odds of cognitive impairment (OR: 1.06, 95% CI: 1.06, 1.07) in our model, the effect of APOE ε4 carriers was equivalent to 2.5 additional years of aging.